| Name | chromosome 22 open reading frame 34 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Chromosome 22 open reading frame 34 (C22orf34) is a protein‐coding gene whose precise biological function remains to be fully characterized. Although several studies have primarily focused on other aspects of stem cell reprogramming, neurodevelopmental disorders, endometrial receptivity, and cancer risk (e.g"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": ", genetic association studies have recently implicated C22orf34 in modulating disease susceptibility. In one study examining drug‐induced interstitial lung disease (DIILD), a single nucleotide variant (SNV) located in intron 1 of C22orf34 was identified as a candidate marker associated with an increased risk of DIILD in cancer patients undergoing chemotherapy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In another investigation using a genome‐wide association approach to assess intestinal permeability in healthy individuals, a top association was mapped to C22orf34, where the presence of a minor allele was linked to decreased lactulose mannitol ratios, suggesting a potential role for this gene in regulating epithelial barrier function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, given that deletions in the distal region of chromosome 22 (22q13.3) are known to contribute to neurodevelopmental and somatic phenotypes in syndromes such as Phelan McDermid syndrome"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ", it is plausible that loss or disruption of C22orf34 in this region might also be associated with aspects of the diverse clinical manifestations observed in these disorders. Although its mechanistic role has yet to be established, the emerging associations with both epithelial barrier regulation and adverse drug effects underscore the potential importance of C22orf34 in modulating susceptibility to complex conditions.\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, while C22orf34 has not been functionally characterized in depth, current genetic association data suggest that variations in this gene may contribute to the risk of DIILD and influence intestinal barrier integrity. Further functional studies are warranted to elucidate the exact mechanisms by which C22orf34 affects these diverse biological processes.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Aline C Planello, Junfeng Ji, Vivek Sharma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Regen (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/2045-9769-3-4"}], "href": "https://doi.org/10.1186/2045-9769-3-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25408883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25408883"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "I Görker, H Gürkan, S Demir Ulusal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A 9-year-old-girl with Phelan McDermid Syndrome, who had been diagnosed with an autism spectrum disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Balkan J Med Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/bjmg-2016-0041"}], "href": "https://doi.org/10.1515/bjmg-2016-0041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28289594"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28289594"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Andrew R Mitz, Travis J Philyaw, Luigi Boccuto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41431-017-0042-x"}], "href": "https://doi.org/10.1038/s41431-017-0042-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29358616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29358616"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Chun Feng, Jin-Ming Shen, Ping-Ping Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.25081"}], "href": "https://doi.org/10.7150/ijbs.25081"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30123082"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30123082"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Alice Blandino, Dominique Scherer, Trine B Rounge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of Circulating lncRNAs Associated with Gallbladder Cancer Risk by Tissue-Based Preselection, Cis-eQTL Validation, and Analysis of Association with Genotype-Based Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancers (Basel) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cancers14030634"}], "href": "https://doi.org/10.3390/cancers14030634"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35158906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35158906"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Chihiro Udagawa, Hidehito Horinouchi, Kouya Shiraishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0223371"}], "href": "https://doi.org/10.1371/journal.pone.0223371"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31584970"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31584970"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Williams Turpin, Osvaldo Espin-Garcia, Larbi Bedrani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Inflamm Bowel Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/ibd/izz116"}], "href": "https://doi.org/10.1093/ibd/izz116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31251335"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31251335"}]}]}]}
|
| Synonyms | C22orf34 |
| Proteins | CV034_HUMAN |
| NCBI Gene ID | 348645 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
C22ORF34 has 1,417 functional associations with biological entities spanning 7 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 31 datasets.
Click the + buttons to view associations for C22ORF34 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of C22ORF34 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of C22ORF34 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of C22ORF34 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of C22ORF34 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of C22ORF34 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of C22ORF34 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with C22ORF34 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with C22ORF34 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at C22ORF34 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of C22ORF34 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of C22ORF34 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of C22ORF34 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of C22ORF34 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of C22ORF34 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of C22ORF34 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of C22ORF34 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of C22ORF34 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with C22ORF34 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with C22ORF34 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with C22ORF34 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of C22ORF34 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of C22ORF34 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of C22ORF34 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of C22ORF34 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of C22ORF34 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of C22ORF34 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain C22ORF34 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of C22ORF34 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of C22ORF34 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at C22ORF34 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of C22ORF34 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |